These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25358897)

  • 1. Platelet transfusion strategy for hematologic cancers.
    Podda GM; Ricci S
    Intern Emerg Med; 2015 Feb; 10(1):81-2. PubMed ID: 25358897
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
    Stanworth SJ; Hyde C; Brunskill S; Murphy MF
    Br J Haematol; 2005 Dec; 131(5):588-95. PubMed ID: 16351634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoplastic thrombocytopenia and platelet transfusion: therapeutic goals.
    Karakatsanis SJ; Papadatos SS; Syrigos KN
    Hosp Pract (1995); 2019 Feb; 47(1):16-23. PubMed ID: 30409035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time ultrasound-guided central venous catheterization reduces the need for prophylactic platelet transfusion in thrombocytopenic patients with hematological malignancy.
    Tomoyose T; Ohama M; Yamanoha A; Masuzaki H; Okudaira T; Tokumine J
    Transfus Apher Sci; 2013 Oct; 49(2):367-9. PubMed ID: 23083962
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylactic platelet transfusion.
    Wandt H; Schäfer-Eckart K; Ehninger G
    N Engl J Med; 2013 Aug; 369(6):577. PubMed ID: 23924012
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylactic platelet transfusion.
    Slichter SJ
    N Engl J Med; 2013 Aug; 369(6):577-8. PubMed ID: 23924011
    [No Abstract]   [Full Text] [Related]  

  • 7. Eliminate prophylactic platelet transfusions?
    Slichter SJ
    N Engl J Med; 2013 May; 368(19):1837-8. PubMed ID: 23656650
    [No Abstract]   [Full Text] [Related]  

  • 8. Haematological cancer: Prophylactic platelet transfusion is frequently not necessary.
    Schiffer CA
    Nat Rev Clin Oncol; 2013 Aug; 10(8):431-2. PubMed ID: 23820637
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
    Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
    Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet transfusions for patients with haematological malignancies: who needs them?
    Estcourt LJ; Stanworth SJ; Murphy MF
    Br J Haematol; 2011 Aug; 154(4):425-40. PubMed ID: 21615375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombocytopenia: is therapeutic platelet transfusion effective? Prophylactic platelet transfusion remains justified].
    Bethge W
    Dtsch Med Wochenschr; 2012 Dec; 137(50):2630. PubMed ID: 23225185
    [No Abstract]   [Full Text] [Related]  

  • 12. Clarify the negatives of the MIRASOL noninferiority trial.
    Strauss RG
    Transfusion; 2011 Jun; 51(6):1361-2; author reply 1362-4. PubMed ID: 21658043
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prophylactic platelet transfusion in patients with hematologic diseases].
    Siitonen T; Koistinen P
    Duodecim; 2004; 120(7):877-84. PubMed ID: 15154309
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of transfusion of platelet concentrates obtained by manual pooling or by semiautomated pooling of buffy-coats: a retrospective analysis of count increment, corrected count increment and transfusion interval.
    Cid J; Ramiro L; Escoda L; Llorente A
    Vox Sang; 2009 Jan; 96(1):29-33. PubMed ID: 19121195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic platelet transfusion for hypoproliferative thrombocytopenia.
    Takahashi Y; Nishikawa Y; Mori J; Hamaki T; Tanimoto T
    Lancet; 2013 Mar; 381(9868):724. PubMed ID: 23472915
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic platelet transfusion for hypoproliferative thrombocytopenia.
    Tsuda K; Morita T; Tsubokura M; Matsumura T; Kami M
    Lancet; 2013 Mar; 381(9868):723-4. PubMed ID: 23472914
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic platelet transfusion for hypoproliferative thrombocytopenia - authors' reply.
    Wandt H; Schaefer-Eckart K
    Lancet; 2013 Mar; 381(9868):724. PubMed ID: 23472916
    [No Abstract]   [Full Text] [Related]  

  • 18. Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.
    Gurevich-Shapiro A; Tzadok S; Rosenberg A; Inbal A; Bar-Natan M; Wolach O; Raanani P
    Acta Haematol; 2017; 137(4):183-190. PubMed ID: 28419992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A consistent approach to platelet transfusion in the NICU.
    Del Vecchio A; Motta M; Radicioni M; Christensen RD
    J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):93-6. PubMed ID: 23025779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).
    Wiita AP; Nambiar A
    Transfusion; 2012 Oct; 52(10):2146-54. PubMed ID: 23113654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.